Literature DB >> 22621628

Anti-CD20 antibody therapy for B-cell lymphomas.

David G Maloney1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621628     DOI: 10.1056/NEJMct1114348

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  100 in total

1.  The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging.

Authors:  Fabricio Montalvao; Zacarias Garcia; Susanna Celli; Béatrice Breart; Jacques Deguine; Nico Van Rooijen; Philippe Bousso
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

Review 2.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

3.  Infectious complications of immune modulatory agents.

Authors:  Ricardo M La Hoz; John W Baddley
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

4.  CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.

Authors:  Zhenhua Ren; Jingya Guo; Jing Liao; Yan Luan; Zhida Liu; Zhichen Sun; Xiaojuan Liu; Yong Liang; Hua Peng; Yang-Xin Fu
Journal:  Clin Cancer Res       Date:  2016-06-27       Impact factor: 12.531

Review 5.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

6.  AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML.

Authors:  Daniel S Pereira; Claudia I Guevara; Liqing Jin; Nathan Mbong; Alla Verlinsky; Ssucheng J Hsu; Hector Aviña; Sher Karki; Joseph D Abad; Peng Yang; Sung-Ju Moon; Faisal Malik; Michael Y Choi; Zili An; Kendall Morrison; Pia M Challita-Eid; Fernando Doñate; Ingrid B J Joseph; Thomas J Kipps; John E Dick; David R Stover
Journal:  Mol Cancer Ther       Date:  2015-05-01       Impact factor: 6.261

Review 7.  Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens.

Authors:  Richard W Childs; Mattias Carlsten
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

Review 8.  Elucidation of monocyte/macrophage dynamics and function by intravital imaging.

Authors:  Rejane Rua; Dorian B McGavern
Journal:  J Leukoc Biol       Date:  2015-07-10       Impact factor: 4.962

9.  Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder: A Case Report.

Authors:  Katrin A Salva; Daniel Bennett; Jack Longley; Joan Guitart; Gary S Wood
Journal:  Am J Dermatopathol       Date:  2015-10       Impact factor: 1.533

10.  Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.

Authors:  Fernando Souza-Fonseca-Guimaraes; Stephen J Blake; Amani Makkouk; Cariad Chester; Holbrook E Kohrt; Mark J Smyth
Journal:  Oncoimmunology       Date:  2016-06-30       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.